Lunai Bioworks (LNAI) Invested Capital (2011 - 2021)
Lunai Bioworks (LNAI) posted quarterly Invested Capital of $3.0 million for Q1 2021, up 47.08% year-over-year from $2.0 million in Q1 2020, and up 42.65% quarter-over-quarter from $2.1 million in Q4 2020.
Lunai Bioworks (LNAI) Invested Capital (2011 - 2021) Analysis & Trends
Lunai Bioworks' Invested Capital history runs 7 years deep, the most recent figure standing at $3.0 million for Q1 2021.
- In Q1 2021, Invested Capital rose 47.08% year-over-year to $3.0 million; the TTM figure through Dec 2021 stood at $3.0 million (down 70.52% YoY), while the FY2020 annual figure was $3.2 million, down 43.84% from the prior year.
- Invested Capital for Q1 2021 stood at $3.0 million, up from $2.1 million in the prior quarter.
- The five-year high for Invested Capital was $23.8 million in Q1 2019, with the low at $2.0 million in Q1 2020.
- The 4-year median for Invested Capital is $4.9 million (2019), against an average of $10.0 million.
- The sharpest annual moves came in 2020 and 2021: Invested Capital tumbled 91.57% in 2020, then jumped 47.08% in 2021.
- Lunai Bioworks' Invested Capital stood at $23.6 million in 2018, then tumbled by 81.71% to $4.3 million in 2019, then tumbled by 52.07% to $2.1 million in 2020, then soared by 42.65% to $3.0 million in 2021.
- Business Quant data shows LNAI's Invested Capital at $3.0 million in Q1 2021, $2.1 million in Q4 2020, and $2.8 million in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2.95 Mn |
| Dec 31, 2020 | 2.07 Mn |
| Sep 30, 2020 | 2.76 Mn |
| Jun 30, 2020 | 3.18 Mn |
| Mar 31, 2020 | 2.01 Mn |
| Dec 31, 2019 | 4.32 Mn |
| Sep 30, 2019 | 5.40 Mn |
| Jun 30, 2019 | 5.67 Mn |
| Mar 31, 2019 | 23.82 Mn |
| Dec 31, 2018 | 23.60 Mn |
| Sep 30, 2018 | 21.42 Mn |
| Jun 30, 2018 | 22.89 Mn |
| Dec 31, 2013 | 38,235.00 |
| Sep 30, 2013 | 38,235.00 |
| Mar 31, 2013 | 38,235.00 |
| Dec 31, 2012 | 38,235.00 |
| Sep 30, 2012 | 38,235.00 |
| Jun 30, 2012 | 33,235.00 |
| Mar 31, 2012 | 22,235.00 |
| Dec 31, 2011 | 17,235.00 |